Fig. 2From: Visual and anatomical outcomes associated with treat-and-extend administration of intravitreal aflibercept for neovascular age-related macular degenerationMean best-corrected visual acuity (BCVA) as logarithm of the minimal angle of resolution units (A) and central retinal thickness (B) as a function of intravitreal aflibercept treatment duration. Errors bars correspond to 95% confidence intervals that extend two standard errors above and below the mean. p < 0.001 (***), p < 0.01 (**), p < 0.05 (*), non-significant (NS)Back to article page